Posted by Michael Wonder on 28 Aug 2024
Life prolonging breast cancer drug receives expanded access on the PBS
28 August 2024 - Australians diagnosed with a type of metastatic breast cancer will now have access to a life prolonging treatment under the PBS from 1 September 2024.
Trastuzumab deruxtecan (Enhertu) will be expanded on the PBS to provide a new treatment option for patients who have been diagnosed with HER2 low unresectable or metastatic breast cancer.
